Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial differences in heart failure therapeutics.

Heart failure clinics - 1 Jan 2010

Ishizawar David, Yancy Clyde

Abstract excerpt

Heart failure in African Americans has a phenotype that is distinct from that in non-African Americans and that demonstrates increased importance of hypertensive etiologies. Trial data demonstrate that African Americans receive significant benefit from beta blockade. Despite differences in the heart failure phenotype, therapy of heart failure in African Americans remains largely the same as in white heart failure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Antihypertensive Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Heart Failure

Share to Nitric Oxide

Share to Nitric Oxide Donors

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 19945062
DOI: 10.1016/j.hfc.2009.08.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial differences in heart failure therapeutics.PMID 19945062Read ↗

Heart failure in African Americans.Semantic proximity Read ↗

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.Semantic proximity Read ↗

Review: Heart failure with preserved ejection fraction in African Americans.Semantic proximity Read ↗

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Hypertension in African Americans.Semantic proximity Read ↗

Race, common genetic variation, and therapeutic response disparities in heart failure.Semantic proximity Read ↗

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.Semantic proximity Read ↗

Heart failure pharmacogenetics: past, present, and future.Semantic proximity Read ↗

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.Semantic proximity Read ↗

New Management Strategies in Heart Failure.Semantic proximity Read ↗

Heart failure in African Americans. New research demands attention to race.Semantic proximity Read ↗

Emerging role of pharmacogenomics in heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.